Director dealings: Scapa CEO ups stake

By Iain Gilbert

Date: Wednesday 12 Jun 2019

(Sharecast News) - Scapa Group revealed on Wednesday that chief executive Heejae Chae had acquired 109,700 ordinary shares in the AIM-listed healthcare and industrials company.Chae, who took over as CEO back in November 2009, purchased the shares at an average price of 183.80p each, for a total transaction value of £201,628.61.

Following the transaction, Chae still has a beneficial interest in 1.64m ordinary shares, representing roughly 1.06% of the group's issued share capital, that have vested but will not be released until March 2020.

Chae agreed to reverse his decision to step down from the group on Monday in order to prepare its response and pursue "all appropriate rights and remedies" against embattled FTSE 250 drugmaker ConvaTec over a supply agreement.